Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

Ann Hematol. 2016 Jan;95(1):145-146. doi: 10.1007/s00277-015-2493-x. Epub 2015 Sep 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Brentuximab Vedotin
  • Drug Resistance, Neoplasm
  • Hodgkin Disease / complications
  • Hodgkin Disease / diagnosis*
  • Hodgkin Disease / drug therapy*
  • Humans
  • Immunoconjugates / therapeutic use*
  • Jaundice / complications
  • Jaundice / diagnosis*
  • Jaundice / drug therapy*
  • Male
  • Middle Aged

Substances

  • Immunoconjugates
  • Brentuximab Vedotin